UPB UPSTREAM BIO INC revenue, earnings and financials
For the quarter ended June 30, 2026, UPSTREAM BIO INC reported revenue of $773K (down 17.5% from a year earlier), net income of −$39.7M and diluted EPS of −$0.73; over the last four quarters revenue was $3.16M and net income −$157M; for the fiscal year ended December 2025 revenue was $2.85M, up 20.4% on the year before.
UPB annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $2.85M, gross profit n/a, operating income −$160M, net income −$143M (margin -5026.0%), EPS −$2.66
- Fiscal year ended Dec 2024: revenue $2.37M, gross profit n/a, operating income −$77.8M, net income −$62.8M (margin -2650.0%), EPS −$5.58
- Fiscal year ended Dec 2023: revenue $2.38M, gross profit n/a, operating income −$40.1M, net income −$20.5M (margin -862.9%), EPS −$12.95
UPB quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $773K (down 17.5% year over year), net income −$39.7M, EPS −$0.73
- Quarter ended Mar 31, 2026: revenue $1.03M (up 82.7% year over year), net income −$40.6M, EPS −$0.75
- Quarter ended Dec 31, 2025 (from the annual report): revenue $668K (up 9.0% year over year), net income −$42.5M, EPS −$0.78
- Quarter ended Sep 30, 2025: revenue $683K (up 12.5% year over year), net income −$33.7M, EPS −$0.63
- Quarter ended Jun 30, 2025: revenue $937K (up 83.7% year over year), net income −$40.0M, EPS −$0.74
- Quarter ended Mar 31, 2025: revenue $566K (down 11.6% year over year), net income −$27.3M, EPS −$0.51
- Quarter ended Dec 31, 2024 (from the annual report): revenue $613K, net income −$21.2M, EPS $12.56
- Quarter ended Sep 30, 2024: revenue $607K (down 2.3% year over year), net income −$16.0M, EPS −$6.96
- Quarter ended Jun 30, 2024: revenue $510K, net income −$14.7M, EPS −$6.50
- Quarter ended Mar 31, 2024: revenue $640K, net income −$10.9M, EPS −$4.68
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$11.8M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $621K, net income −$3.10M, EPS −$2.11
- Quarter ended Jun 30, 2023: revenue n/a, net income −$2.54M, EPS n/a
- Quarter ended Mar 31, 2023: revenue n/a, net income −$3.06M, EPS n/a
UPB cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$133M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$59.2M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$37.9M, share buybacks n/a
UPB balance sheet
- Jun 30, 2026: cash $79.4M, total assets $281M, total liabilities $10.2M, shareholders' equity $271M
- Mar 31, 2026: cash $96.7M, total assets $318M, total liabilities $14.1M, shareholders' equity $304M
- Dec 31, 2025: cash $102M, total assets $354M, total liabilities $14.0M, shareholders' equity $340M
- Sep 30, 2025: cash $72.2M, total assets $391M, total liabilities $12.6M, shareholders' equity $379M
- Jun 30, 2025: cash $45.5M, total assets $421M, total liabilities $11.8M, shareholders' equity $409M
- Mar 31, 2025: cash $71.3M, total assets $456M, total liabilities $10.6M, shareholders' equity $446M
- Dec 31, 2024: cash $326M, total assets $482M, total liabilities $11.9M, shareholders' equity $470M
- Sep 30, 2024: cash $32.9M, total assets $233M, total liabilities $12.1M, shareholders' equity −$160M
What is UPB's revenue?
UPSTREAM BIO INC reported $3.16M of revenue over its last four quarters, through June 30, 2026.
Is UPB profitable?
No. UPSTREAM BIO INC lost $157M over the last four quarters.
What is UPB's EPS?
Diluted earnings per share over the last four quarters were −$2.89; −$0.73 in the latest quarter.